QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $500K invested in Qualigen Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.71M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$78.4K
2
+$46K
3
+$13K
4
Creative Planning
Creative Planning
Kansas
+$11K
5
UBS Group
UBS Group
Switzerland
+$9K

Top Sellers

1
-$206K
2
-$30K
3
-$6K
4
Wells Fargo
Wells Fargo
California
-$1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$244K
2
$112K
3
$49K
4
$46K
5
$13K
6
$11K
7
$10K
8
$9K
9
$4K
10
$1K
11
$1K
12
–
13
–